PT  - JOURNAL ARTICLE
AU  - Jianian Hua
AU  - Hezi Jiang
AU  - Qi Fang
TI  - Sleep Duration and the Risk of Metabolic Syndrome: a Systematic Review and Meta-analysis
AID  - 10.1101/2020.08.30.20184747
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.08.30.20184747
4099  - http://medrxiv.org/content/early/2020/09/03/2020.08.30.20184747.short
4100  - http://medrxiv.org/content/early/2020/09/03/2020.08.30.20184747.full
AB  - Objective Epidemiologic studies have reported inconsistent findings about the association between sleep duration and metabolic syndrome. We aimed to clarify this association by method of metaanalysis.Methods Medline, Embase, CINAHL and PsycINFO databases were searched from inception to May 2020. We collected data from 235,895 participants from 9 prospective cohort studies, and 340,492 participants from 26 cross-sectional studies. Risk ratios (RR) or odds ratios (OR) were calculated separately for cohort studies and cross-sectional studies, through meta-analysis of adjusted data from individual studies.Results For cohort studies, short sleep duration was associated with an increased risk of metabolic syndrome (RR, 1.15; 95% CI, 1.05-1.25). Long sleep duration was not associated with new onset metabolic syndrome (RR, 1.02, 0.85-1.18). For cross-sectional studies, both short (OR, 1.12, 95% CI, 1.08-1.18) and long (OR, 1.06, 1.01-1.11) sleep duration was associated with high prevalence of metabolic syndrome.Conclusions Only short sleep duration was associated with an increased risk of metabolic syndrome. Future studies should address whether the association is casual and modifiable.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This is a meta-analysis.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis is a meta-analysis